By: Susan Kreimer 06 December 2010 Poor reimbursement may hinder pediatricians from using combination vaccines in their practices, a new national survey suggests. The study appears in the December issue of the Archives of Pediatrics & Adolescent Medicine More than half of survey participants said their practices did not receive adequate reimbursement for the purchase […]
Preemies Have Reduced Response to Pneumococcal Vaccine
By: Todd Neale, Senior Staff Writer, MedPage Today 03 December 2010 Although preterm infants have a response to seven-valent pneumococcal conjugate vaccine (PCV7), it does not result in the antibody levels achieved by full-term infants for all serotypes, researchers found. After an initial three-dose immunization series by age 4 months, antibody titers increased for both […]
Gardasil for Back Door Sex? I'm Still Uncomfortable
Gardasil for Back Door Sex? I’m Still Uncomfortable
Posted by Julie Ryan Evans
on January 19, 2011 at 2:55 PM
Gardasil, the controversial vaccine that’s touted to protect against the human papillomavirus (HPV), was recently approved to prevent anal cancer. Because, you know, the back door method and all …
It’s already being used to prevent cancer in the standard lady parts (cervix, vulva, and vagina) and to stop vaginal warts for both men and women. So, the fact that Gardasil adds another cancer to its score card seems great on the surface, right?
But when you look closely at this vaccine and what it does, it leaves many questions as to whether it does more harm than good, and if promoting more of its powers is wise before safety concerns are quelled.
Grant launches cervical cancer-free Indiana iniative
By: Indiana University School of Medicine 02 December 2010 Indiana will join a multi-state program focused on cervical cancer prevention thanks to an unrestricted gift from GlaxoSmithKline Pharmaceuticals to the Indiana University School of Medicine, in partnership with the Kristen Forbes EVE Foundation. Cervical Cancer-Free America (CCFA) is an initiative designed to raise awareness, increase […]
GSK, Binnopharm aim for Russia’s vaccine market
By: Tracy Staton 29 November 2010 GlaxoSmithKline has teamed up with another emerging markets partner. The drugmaker inked a deal with Russian vaccine firm JSC Binnopharm to make and sell several of its big vaccines in that country. It’s just the latest in a series of tie-ups in developing countries for GSK, which is pinning […]
- « Previous Page
- 1
- …
- 442
- 443
- 444
- 445
- 446
- …
- 575
- Next Page »